NGMC BARROW — History
CCN 110045 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$46M
Latest Revenue (FY2022)
+17.9%
Revenue CAGR (3yr)
-8.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $33M | $45M | $46M | +1.2% | +17.9% |
| Operating Expenses | $41M | $45M | $49M | +10.3% | +9.7% |
| Operating Margin | -24.7% | 0.9% | -8.0% | -959.9% | +0.0% |
| Net Income | $-8M | $0M | $-4M | -970.3% | +0.0% |
| Licensed Beds | 56 | 56 | 56 | +0.0% | +0.0% |
| Total Patient Days | 5,456 | 7,590 | 6,406 | -15.6% | +8.4% |
| Medicare Day % | 20% | 16% | 22% | +36.4% | +5.4% |
| Medicaid Day % | 11% | 8% | 7% | -13.3% | -21.9% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +39.1% ($33M → $46M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+17.9%
This Hospital
+7.6%
State Avg
Latest Margin
-8.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $52M | 0.4% |
| FY2024 (proj) | $59M | 8.7% |
| FY2025 (proj) | $65M | 17.1% |